tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ACRV Stock Latest News

Acrivon Therapeutics files to sell 15.295M shares of common stock for holders
The FlyAcrivon Therapeutics files to sell 15.295M shares of common stock for holders
2d ago
ACRV
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
PremiumPress Releases
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
3d ago
ACRV
Acrivon Therapeutics presents data at AACR meeting
PremiumThe Fly
Acrivon Therapeutics presents data at AACR meeting
10d ago
ACRV
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
PremiumPress Releases
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
10d ago
ACRV
Acrivon Therapeutics Secures $130M for Drug Development Expansion
PremiumCompany Announcements
Acrivon Therapeutics Secures $130M for Drug Development Expansion
11d ago
8K
ACRV
Acrivon to sell 8.24M shares at $8.50 in private placement financing
PremiumThe FlyAcrivon to sell 8.24M shares at $8.50 in private placement financing
11d ago
ACRV
Ladenburg ‘more suspicious’ about Acrivon upcoming data, cuts target
PremiumThe Fly
Ladenburg ‘more suspicious’ about Acrivon upcoming data, cuts target
15d ago
ACRV
Acrivon Therapeutics price target lowered to $21 from $25 at Oppenheimer
PremiumThe Fly
Acrivon Therapeutics price target lowered to $21 from $25 at Oppenheimer
22d ago
ACRV
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
PremiumPress Releases
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
23d ago
ACRV
Acrivon Therapeutics reports Q4 EPS (86c), consensus (73c)
PremiumThe Fly
Acrivon Therapeutics reports Q4 EPS (86c), consensus (73c)
23d ago
ACRV
ACRV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ACRV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
ACRV
Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316
PremiumPress Releases
Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316
2M ago
ACRV
Acrivon Therapeutics Welcomes New Director Santhosh Palani
PremiumCompany AnnouncementsAcrivon Therapeutics Welcomes New Director Santhosh Palani
2M ago
8K
ACRV
Acrivon Therapeutics appoints Santhosh Palani to board of directors
PremiumThe Fly
Acrivon Therapeutics appoints Santhosh Palani to board of directors
2M ago
ACRV
Acrivon Therapeutics initiated with an Outperform at JMP Securities
PremiumThe Fly
Acrivon Therapeutics initiated with an Outperform at JMP Securities
2M ago
ACRV
Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference
PremiumPress Releases
Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference
2M ago
ACRV
Acrivon Therapeutics Welcomes New Board Member Dr. Magovcevic-Liebisch
PremiumCompany Announcements
Acrivon Therapeutics Welcomes New Board Member Dr. Magovcevic-Liebisch
2M ago
8K
ACRV
Acrivon Therapeutics appoints Magovcevic to board of directors
PremiumThe Fly
Acrivon Therapeutics appoints Magovcevic to board of directors
2M ago
ACRV
VIGL
Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2M ago
ACRV
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesAcrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
ACRV
Acrivon Therapeutics appoints Cuillerot as Chief Medical Officer
PremiumThe Fly
Acrivon Therapeutics appoints Cuillerot as Chief Medical Officer
4M ago
ACRV
Acrivon Therapeutics assumed with a Buy at Jefferies
PremiumThe Fly
Acrivon Therapeutics assumed with a Buy at Jefferies
4M ago
ACRV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >